by Nicola Blackburn | Dec 28, 2022
2022 was another year of facing and overcoming challenges for people around the world. As we move into a new year, it is a good time to reflect on achievements and accomplishments. Throughout the year, the APGI has continued to support Pancreatic Cancer research...
by Nicola Blackburn | Nov 16, 2022
In recognition of Pancreatic Cancer Awareness Month, this November iconic buildings over Australia will light up purple to raise awareness for the disease and to celebrate and honour survivors and loved ones. Pancreatic cancer is the third leading cause of cancer...
by Nicola Blackburn | Sep 9, 2022
A new clinical trial for people with advanced pancreatic cancer, has now commenced in Australia. The trial led by Amplia Therapeutics, in collaboration with Professor Paul Timpson from the Invasion and Metastasis Lab at The Garvan Institute of Medical Research, will...
by Nicola Blackburn | Nov 1, 2021
A new approach to ‘prime’ the tumour environment may improve how effective chemotherapy is for pancreatic ductal adenocarcinoma, one of the most aggressive forms of pancreatic cancer. In preclinical models, a team from the Invasion and Metastasis Lab at The Garvan...
